Cargando…

Anakinra authorized to treat severe coronavirus disease 2019; Sepsis breakthrough or time to reflect?

INTRODUCTION: The European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA) announced conditions for using recombinant human interleukin-1 receptor antagonist (rhIL-1ra) to treat hospitalized patients with Coronavirus disease 2019 (COVID-19) and risk for progression. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shapiro, Leland, Scherger, Sias, Franco-Paredes, Carlos, Gharamti, Amal, Henao-Martinez, Andrés F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620707/ https://www.ncbi.nlm.nih.gov/pubmed/37928695 http://dx.doi.org/10.3389/fmicb.2023.1250483

Ejemplares similares

Chasing the Ghost: Hyperinflammation Does Not Cause Sepsis
por: Shapiro, Leland, et al.
Publicado: (2022)

Association between cytokine levels, sepsis severity and clinical outcomes in sepsis: a quantitative systematic review protocol
por: Gharamti, Amal, et al.
Publicado: (2021)

1003. Cytokine Levels in Sepsis and TNFα Association with Mortality but not Sepsis Severity or Infection Source: a Systematic Review and Meta-analysis
por: Gharamti, Amal, et al.
Publicado: (2021)

Pneumocystis jirovecii pneumonia: a proposed novel model of corticosteroid benefit
por: Gharamti, Amal A., et al.
Publicado: (2021)

Diagnostic utility of a Ferritin-to-Procalcitonin Ratio to differentiate patients with COVID-19 from those with Bacterial Pneumonia: A multicenter study
por: Gharamti, Amal A., et al.
Publicado: (2020)

Diagnostic Utility of a Ferritin-to-Procalcitonin Ratio to Differentiate Patients With COVID-19 From Those With Bacterial Pneumonia: A Multicenter Study
por: Gharamti, Amal A, et al.
Publicado: (2021)

Rethinking interleukin-6 blockade for treatment of COVID-19
por: Scherger, S., et al.
Publicado: (2020)

COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugs
por: Rodriguez-Morales, Alfonso J., et al.
Publicado: (2021)

Comparison of Anakinra and Tocilizumab in Anticytokine Therapy in the Treatment of Coronavirus Disease-2019
por: Ozkan, Feyza, et al.
Publicado: (2022)

COVID-19 epidemic in the US—A gateway to screen for tuberculosis, HIV, viral hepatitides, Chagas disease, and other neglected tropical diseases among Hispanics
por: Schultz, Jonathan, et al.
Publicado: (2020)

Previous corticosteroid exposure associates with an increased Pneumocystis jirovecii pneumonia mortality among HIV-negative patients: a global research network with a follow-up multicenter case-control study
por: Vargas Barahona, Lilian, et al.
Publicado: (2023)

Acute Toxoplasma Dissemination With Encephalitis in the Era of Biological Therapies
por: Gharamti, Amal A, et al.
Publicado: (2018)

Anakinra for patients with COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

Effect of anakinra in COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

1171. Lower Mortality with Adjuvant Corticosteroid Therapy in non-HIV Infected Patients with pneumocystis jirovecii pneumonia: A Single US Cohort Study and a Proposed Novel Mechanism of Corticosteroids
por: Mundo, William, et al.
Publicado: (2020)

Increased mortality associated with uncontrolled diabetes mellitus in patients with pulmonary cryptococcosis: a single US cohort study
por: Archuleta, Solana, et al.
Publicado: (2021)

Anakinra for severe forms of COVID-19 – Authors' reply
por: Hayem, Gilles, et al.
Publicado: (2020)

Intravenous anakinra for cytokine storm syndromes – Authors' reply
por: Mehta, Puja, et al.
Publicado: (2020)

Booster vaccines for COVID-19 vaccine breakthrough cases? – Authors' reply
por: Krause, Philip R, et al.
Publicado: (2022)

Monkeypox – a description of the clinical progression of skin lesions: a case report from Colorado, USA
por: Ortiz-Martínez, Yeimer, et al.
Publicado: (2022)

Countermeasures to Coronavirus Disease 2019: Are Immunomodulators Rational Treatment Options—A Critical Review of the Evidence
por: Chastain, Daniel B, et al.
Publicado: (2020)

Preventing SARS-CoV-2 infection by blocking a tissue serine protease
por: Jankousky, Katherine C., et al.
Publicado: (2020)

Evaluation of anakinra in the management of patients with COVID-19 infection: A randomized clinical trial
por: Elmekaty, Eman Zeyad I., et al.
Publicado: (2023)

Combating sepsis: bottlenecks to breakthroughs
Publicado: (2023)

Disseminated tuberculosis in a lung transplant recipient presenting as tenosynovitis, subcutaneous nodules, and liver abscesses
por: Vargas Barahona, Lilian, et al.
Publicado: (2022)

Intravenous Anakinra for Macrophage Activation Syndrome May Hold Lessons for Treatment of Cytokine Storm in the Setting of Coronavirus Disease 2019
por: Wampler Muskardin, Theresa L.
Publicado: (2020)

Early introduction of anakinra improves acute pericarditis and prevents tamponade in Staphylococcal sepsis
por: Sicignano, Ludovico Luca, et al.
Publicado: (2021)

Editorial: Latest breakthroughs in microbial electrochemistry research
por: Puig, Sebastià, et al.
Publicado: (2022)

Coronavirus Disease 2019: Clinics, Treatment, and Prevention
por: Burkert, Francesco Robert, et al.
Publicado: (2021)

Clinical Considerations During Breakthrough Coronavirus Disease 2019 Infections in Vaccinated Individuals With Autoimmunity
por: Rocco, Joseph M, et al.
Publicado: (2021)

419. Diagnostic Utility of a Ferritin to Procalcitonin Ratio to Differentiate Patients with COVID-19 from Those with Bacterial Pneumonia
por: Jankousky, Katherine C, et al.
Publicado: (2020)

473. Diabetes Mellitus as a Risk Factor for Cryptococcosis — a Multicenter Research Network Study
por: Kung, Vanessa, et al.
Publicado: (2022)

Science and technology breakthroughs to advance artificial cultivation of true morels
por: Liu, Qi Zheng, et al.
Publicado: (2023)

Corticosteroid use in viral pneumonia: experience so far and the dexamethasone breakthrough in coronavirus disease-2019
por: Rafiullah, Mohamed, et al.
Publicado: (2020)

Coronavirus diseases 2019 (COVID-19) response: Highlights of Ghana's scientific and technological innovativeness and breakthroughs
por: Sibiri, H., et al.
Publicado: (2020)

Vaccine breakthrough infections in veterans hospitalized with coronavirus infectious disease-2019: A case series
por: Kim, Paul S., et al.
Publicado: (2022)

Severity of Coronavirus Disease 2019 (COVID-19): Does Surfactant Matter?
por: Weiskirchen, Ralf
Publicado: (2020)

Anakinra for patients with COVID-19
por: Maoujoud, Omar, et al.
Publicado: (2020)

Anakinra for patients with COVID-19
por: Valette, Xavier, et al.
Publicado: (2020)

Anakinra for patients with COVID-19
por: Martin-Silva, Nicolas, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_199u9ic372v1rm8p6e5osl9qqc